Biofuel catalyst maker Codexis abandons $100 million IPO, citing market conditions

In New York, biocatalyst developer Codexis, which numbers Chevron, Bio*One Capital and Pfizer among its investors, cancelled a $100 million IPO, citing “unfavorable market conditions”. The company manufacturers catalysts for the biofuels and biotech industries. Shell had invested in the company last November to explore catalysts for biofuels.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Codexis licenses biomanufacturing technology for $10 million, to improve enzyme production cycle time

In Florida, Dyadic International announced that it has licensed its biomanufacturing technology to Codexis for $10 million. Codexis said that it would use the technology in conjunction with its synthe...

Renewable Energy Group cancels $150 million IPO, citing market conditions

In Iowa, Renewable Energy Group cancelled its $150 million IPO, citing poor market conditions. The company had hoped to use proceeds from the IPO to fund one-third of the construction costs of 180 Mgy...

Shell Oil to expand investment in Codexis, adds one more board seat; Codexis to further optimize Shell-Iogen cellulosic ethanol biocatalysts

In California, Codexis announced that it has received an increased investment from Shell to accelerate its development timetable for commercial biofuels. The company said that Shell will also take an ...

Shell purchases stake in Codexis, an enzyme manufacturer for cellulosic ethanol

Shell has purchased an undisclosed stake in stake in Codexis, a company which manufactures enzymes for the cellulosic ethanol production process. Codexis executives said that they expect to build a co...

Dyadic receives last installment in $10 million payment from Codexis for enzyme production system

In Florida, Dyadic filed an SEC 8-K form confirming that the company has received the final installment in $10 million in upfront payments from Codexis for a license to utilize "the use of Dyadic's C1...

Codexis CEO: “We’re hitting escape velocity” as Shell deepens ties to enzymes pioneer

At WBM 2009, Codexis CEO Alan Shaw offered more details on the company's expansion, including a new investment from Shell Oil rumored to be on the $30 million scale. "In a way, Shell is like IBM and w...